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Chromosomal translocations are a hallmark of
leukemia/lymphoma and also appear in solid tumors,
but the underlyingmechanism remains elusive. By es-
tablishing a cellular model that mimics the relative
frequency of authentic translocation events without
proliferation selection, we report mechanisms of
nuclear receptor-dependent tumor translocations. In-
tronicbindingof ligandedandrogen receptor (AR) first
juxtaposes translocation loci by triggering intra- and
interchromosomal interactions. AR then promotes
site-specific DNA double-stranded breaks (DSBs) at
translocation loci by recruiting two typesof enzymatic
activities induced by genotoxic stress and liganded
AR, including activation-induced cytidine deaminase
and the LINE-1 repeat-encoded ORF2 endonuclease.
Theseenzymessynergisticallygeneratesite-selective
DSBs at juxtaposed translocation loci that are ligated
by nonhomologous end joining pathway for specific
translocations. Our data suggest that the confluence
of two parallel pathways initiated by liganded nuclear
receptor and genotoxic stress underlies nonrandom
tumor translocations, which may function in many
types of tumors and pathological processes.
INTRODUCTION
Chromosomal translocations, caused by rearrangement of
nonhomologous chromosomes (Aplan, 2006), have been well
described in leukemia and lymphomas (Greaves and Wiemels,
2003), but their occurrence in solid tumors is increasingly recog-
nized, particularly in prostate cancer (Tomlins et al., 2005). It has
been recognized that prevalent tumor translocations may be
responsible for certain aggressive behaviors of prostate cancerC(Wang et al., 2006). Androgen and its derivatives, which act
via the androgen receptor (AR), are not only essential for
development of the prostate gland, but also instrumental to
prostate carcinogenesis (Heinlein and Chang, 2004). Recently,
some high-frequency gene fusion events have been discovered
in prostate cancers, which involve translocation of the 50
untranslated region of the AR target gene TMPRSS2 to two
members of the ETS family of genes, ERG and ETV1 (Tomlins
et al., 2005). These gene fusion events, which may be present
in 50%–70% of prostate cancers, render specific members of
the ETS family of genes under the control of androgens; such
acquired androgen-dependent expression or overexpression
of the ETS genes has been proposed to provide a key driving
force to the development or aggressiveness of prostate cancers
(Shaffer and Pandolfi, 2006).
While the linkage between chromosomal translocations and
various forms of cancer has founded the theoretical grounds
for cancer diagnosis and therapeutics, particularly for leukemia
and lymphomas (Corral et al., 1996; Krivtsov and Armstrong,
2007), the underlying molecular mechanisms have remained
incompletely understood. Although it is well established that
transcriptionally active regions, such as promoters, can be
particularly susceptible to DNA damage (Aguilera and Gomez-
Gonzalez, 2008; Thomas and Rothstein, 1989), a prevalent
view has been that tumor translocations may initially result
from random chromosome rearrangement events, which are ulti-
mately selected based on the proliferative and/or antiapoptotic
advantage provided by specific fusion gene products. However,
precedents such as gross chromosomal rearrangements (GCRs)
in yeast (Myung et al., 2001), V(D)J recombination, and class
switch recombination (CSR) during T and B cell development
(Chaudhuri and Alt, 2004) argue for a role of genetically based
and cell lineage-specific juxtaposition of translocation loci,
which may facilitate specific chromosomal translocations
(Jhunjhunwala et al., 2008; Neves et al., 1999; Nikiforova et al.,
2000; Roix et al., 2003). Because many types of cancer occur
in tissues in which specific transcription factors may exert criticalell 139, 1069–1083, December 11, 2009 ª2009 Elsevier Inc. 1069
Figure 1. Liganded-AR and Genotoxic
Stress Synergistically Induce Chromosomal
Translocations in Prostate Cancer Cells
(A and B) Identification and characterization of
induced TMPRSS2:ERGb and TMPRSS2:ETV1b
translocations in LNCaP cells. Top: schematic
structures for the TMPRSS2, ERG, and ETV1
mRNA indicating exon positions. Middle: RT-
PCR amplification of TMPRSS2:ERGb (A) or
TMPRSS2:ETV1b (B) fusion transcripts from 48
individual cell samples. Bottom: confirmation of
position and fusion sites by automated DNA
sequencing.
(C and D) Statistical analysis of DHT- and IR-
induced TMPRSS2:ERG (C) and TMPRSS2:ETV1
(D) translocations (n = 3, ± SEM).
(E and F) Identification and characterization of
induced TMPRSS2:ERG (E) and TMPRSS2:ETV1
(F) translocation isoforms in LNCaP cells. Bottom:
summary of distinct fusion types.
(G and H) Involvement of DNA repair machinery in
induced TMPRSS2:ERGb and TMPRSS2:ETV1b
translocations by quantitative PCR with indicated
siRNAs (n = 3, ± SEM).
*p < 0.05, ***p < 0.001.roles in tumor development, a potential mechanistic relationship
between regulated transcription and the strategies that underlie
tumor translocations, if any, remain an intriguing question.
Here, we present evidence that tumor translocations involving
TMPRSS2, ERG, and ETV1 in prostate cancer are nonrandom
events, which require two critical roles of AR: (1) ligand-depen-
dent binding of AR to intronic binding sites near the tumor trans-
location sites, causing chromosomal movements that result in
specific intra- and interchromosomal interactions to create the
spatial proximity for tumor translocation partners, and (2) the
actions of intron-bound AR to both alter local chromatin archi-
tecture and recruit the ligand and genotoxic stress-induced
enzymes, including the activation-induced cytidine deaminase
(AID) and LINE-1 repeat-encoded ORF2 endonuclease to these
specific regions for facilitating DNA double-stranded break1070 Cell 139, 1069–1083, December 11, 2009 ª2009 Elsevier Inc.(DSB) generation. The generated DSBs
are subsequently ligated by the nonho-
mologous end joining (NHEJ) machinery.
These findings elucidate several unex-
pected general principles for nonrandom
chromosomal translocations in tumors.
RESULTS




Because of the critical roles of AR in pros-
tate development and tumor progression
and the observation that genotoxic stress
is able to rapidly induce chromosomal
translocations (Deininger et al., 1998),
we first investigated whether androgen treatment and genotoxic
stress, either alone or in combination, might induce chromo-
somal translocations of TMPRSS2:ERG and TMPRSS2:ETV1.
To establish a cellular model, we utilized androgen-responsive
LNCaP prostate cancer cells in which these chromosomal
translocations had not occurred (Tomlins et al., 2005).
Surprisingly, the treatment of LNCaP cells with both dihydro-
testosterone (DHT; 107 M) and irradiation (IR) (50 Gy) dramati-
cally induced both TMPRSS2:ERGb and TMPRSS2:ETV1b
fusion transcripts in 24 hr, with similar effects reproducibly
observed at lowered levels of DHT (109 M) and IR (10 Gy)
(Figures 1A and 1B and data not shown). Sequencing of induced
fusion transcripts confirmed that they represented the authentic
translocation fusion junctions (Figures 1A and 1B). The cell
viability did not differ significantly after 24 hr treatment. Actin
expression was equivalent among samples (Figure S1 available
online). Other modalities that cause genotoxic stress, including
Etoposide and Doxorubicin, when combined with the DHT treat-
ment, also induced tumor translocation (Figures S3A and S3B).
To quantitate the frequency at which each type of fusion
transcript was formed, 48 individual sets of cells were exposed
(24 hr) to either DHT alone, IR alone, or both. RT-PCR analyses
of TMPRSS2:ERGb and TMPRSS2:ETV1b fusion transcripts
revealed that either treatment gave rise to a reproducible, but
minimal, induction of the fusion transcripts, but the combined
treatment exhibited an unequivocal, striking synergy (Figures 1C
and 1D). The frequency of these chromosomal translocations
in LNCaP cells was estimated by dilution experiments to be
1 event/10,000 cells (vide infra).
The finding that eight isoforms of TMPRSS2:ERG fusion
transcripts have been identified in prostate cancer (Wang et al.,
2006) led us to detect all potential induced fusion isoforms using
primers targeting the first exon of TMPRSS2 and the last exon of
ERG or ETV1, respectively (Figures 1E and 1F). This analysis
revealed that the frequency of each induced TMPRSS2:ERG
fusion isoform in LNCaP cells was very similar to that identified
in prostate cancer tissues (Wang et al., 2006) (Figures 1E and
S2). Together, these data demonstrated that our cellular model
and treatment conditions authentically recapitulate the in vivo
chromosomal translocation events, and, surprisingly, these
specific patterns are established without proliferation selection.
To determine whether the generation of chromosomal translo-
cation has cell-type specificity, we analyzed IR-induced BCR:
ABL1 translocation in KG-1 cells (Deininger et al., 1998) (Fig-
ure S4A) and LNCaP cells. Although BCR and ABL1 are ex-
pressed in LNCaP cells at a detectable level (Figures S4B and
S4C), IR (50 Gy) induced BCR:ABL1 fusion in KG-1 cells at an
efficiency 8-fold higher than that in LNCaP cells (Figure S4D).
Conversely, irradiation of LNCaP cells induced TMPRSS2:ERGb
or TMPRSS2:ETV1b fusion >10-fold more efficiently than in
KG-1 cells under the same conditions (Figures S4E and S4F).
These observations demonstrated that general genotoxic stress
signals preferentially induce gene fusions in a nonrandom, cell
type-specific fashion.
Using validated small interfering RNAs (siRNAs) to target
specific components of the homologous recombination (HR),
NHEJ, or microhomology-mediated end joining (MMEJ) path-
ways (Figure S8A), we found that knockdown of individual
components of the NHEJ pathway generally attenuated the
induction of both TMPRSS2:ERGb and TMPRSS2:ETV1b fusion
transcripts, suggesting the error-prone NHEJ as the major repair
mechanism to generate fusion genes (Figure 1G). Removal of
the major components of the HR pathway actually enhanced
the induction of TMPRSS2:ERGb translocations (Figure 1H).
Knockdown of individual components of several other DNA
damage repair pathways did not show any significant effect on
the chromosomal translocation types we tested (Figure S5 and
data not shown).
Liganded AR Induces Intra- and Interchromosomal
Interactions Required for Translocations
On the basis of the dynamic reorganization of chromosomes
during development or in response to specific signals (CremerCet al., 2006), we investigated whether one role of AR might be
to mediate androgen-dependent spatial proximity of the
corresponding chromosomal translocating regions. ERG and
TMPRSS2 are both located on chromosome 21 (Chr21), 3
megabases apart, while the ETV1 gene is located on chromo-
some 7 (Chr7). As TMPRSS2 is a well-established direct
AR target gene (Lucas et al., 2008), we tested whether DHT
induced specific intra- and interchromosomal interactions
between these regions.
To avoid potential complications associated with aneuploidy
of cancer cells, we focused on normal prostate epithelial cells
(PrECs). While TMPRSS2 and ERG genes were independently
localized in the nuclei of mock-treated PrECs, DHT stimulation
(1 hr) induced the apparent colocalization of these two genes
in 25% of cells, with about half exhibiting monoallelic interac-
tions and the other half biallelic interactions as revealed by
FISH analysis (Figure 2A). We performed a similar analysis for
the TMPRSS2 and ETV1 genes in PrECs, which exhibited
DHT-induced colocalization in 10%–15% of cells, the majority
being monoallelic interactions (Figure 2B). We observed similar
induced colocalization in LNCaP cells (Figures S6A and S6B).
In contrast, the BCR and ABL1 gene loci did not show any
DHT-dependent colocalization, suggesting the specificity of
DHT-dependent chromosomal interactions (Figure S6C).
On the basis of the reported role of nuclear actin in transcrip-
tional activation (Hofmann and de Lanerolle, 2006), we examined
whether a nuclear myosin I (NMI)/actin-dependent mechanism
might be involved in mediating intra- and interchromosomal
interactions in PrECs, as recently documented for breast
epithelial cells (Hu et al., 2008). Treatment of DHT-stimulated
PrECs with jasplakinolide (Jpk), which specifically inhibits
depolymerization of actin networks (Holzinger, 2001), caused
almost a complete loss of DHT-induced interchromosomal
(TMPRSS2:ETV1) interactions but did not affect intrachromoso-
mal (TMPRSS2:ERG) interactions (Figures 2C and 2D). Likewise,
single-cell nuclear microinjection of siRNA that specifically
targeted NMI (Grummt, 2006) had little effect on intrachromoso-
mal (TMPRSS2:ERG) interactions but caused a complete loss of
the DHT-induced TMPRSS2:ETV1 interchromosomal interac-
tions (Figures 2E and 2F). Similar results were also obtained by
single-cell nuclear microinjection of a neutralizing antibody
against NMI, which could be functionally rescued by coinjection
of a plasmid expressing wild-type NMI, but not mutant NMI
that fails to bind to ATP (Wang et al., 2003) (Figures 2G
and S7). LNCaP cells treated with latrunculin (LtA), which
blocks actin polymerization (Rizk and Walczak, 2005), or Jpk
exhibited inhibition of induced TMPRSS2:ETV1 translocations,
as was observed with an siRNA that specifically targeted NMI
(Figures 2H and 2I). Together, these observations reveal the
mechanistic link between ligand-induced, nuclear myosin/actin
motor system-dependent interchromosomal proximity and
tumor translocations.
Mapping TMPRSS2:ERG and TMPRSS2:ETV1
Translocation Breakpoints
To identify the potential DSBs in the corresponding introns of
the two translocation partners, we adapted a protocol of
BrdU labeling by terminal deoxynucleotide transferase (TdT)ell 139, 1069–1083, December 11, 2009 ª2009 Elsevier Inc. 1071
Figure 2. AR-Induced and Motor-Dependent Chromosomal Interactions of TMPRSS2 and ERG or ETV1 Loci
(A and B) Interphase FISH analysis on PrEC cells with TMPRSS2 (green), ERG (red) (A), or ETV1 (red) (B) probes.
(C and D) Actin polymerization-dependent interchromosomal interactions.
(E and F) Nuclear myosin-dependent interchromosomal interactions.
(A–F) Columns, mean of three experiments (>100 cell per sample per experiment); bars, ± SEM.
(G) ATPase activity of NMI is required for DHT-induced interchromosomal interactions.
(H and I) Requirement of nuclear myosin/actin motor system for induced TMPRSS2:ERGb and TMPRSS2:ETV1b translocations in LNCaP cells pretreated with
latrunculin (LtA) or jasplakinolide (Jpk) (H) or transfected with NMI siRNA (I) (n = 3, ± SEM).
*p < 0.05, **p < 0.01.
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(Ju et al., 2006) coupled with ChIP sequencing (ChIP-seq) anal-
ysis to detect potential DNA breaks in response to DHT,
genotoxic stress, or both. To test the potential efficacy of this
protocol for high-throughput screening experiments, we took
advantage of the inducible 4-OHT-I-PpoI systems to generate
specific cleavage sites on chromosome 1 (Berkovich et al.,
2008) and labeled these sites with BrdU. Indeed, anti-BrdU
ChIP assay showed that after induction with 4-OHT, both the
50 and 30 chromatin fragments at the cleavage site, but not the
flanking region, could be labeled by BrdU (Figure S9). By
applying this protocol to LNCaP cells, our data revealed one
potential breakpoint located within or nearby intron 1 of the
TMPRSS2 gene (region I), two potential breakpoints located
within intron 3 of ERG gene (regions II and III), and one potential
breakpoint in the ETV1 gene intron 3 (region IV) (Figure 3A).
Compared to mock treatment, DHT induced an 6- to 10-fold
change at each of these putative DSBs (Figure 3B). These puta-
tive sites were further confirmed by conventional ChIP analysis,
in DHT- or DHT+IR-treated LNCaP cells (Figures 3C and 3D).
As illustrated in Figure 3A, amplification with primer pairs
flanking region II and I resulted in a single PCR product
(Figure 3E, band a) containing a breakpoint between nucleotides
Chr21 38819940–38819946 on the ERG gene and nucleotides
Chr21 41792689–41792695 on the TMPRSS2 gene (Figure 3E),
which confirms that the DNA breaks identified in these pilot
experiments corresponded to actual translocation breakpoints
in these genes. Taking advantage of a finding that simultaneous
cotransfection of FLAG-DOT1L (encoding an H3K79 methyl-
transferase) expression plasmid and MeCP2 siRNA into LNCaP
cells resulted in a 60-fold induction of fusion transcript
(Figure S10), we amplified two additional PCR products (Fig-
ure 3F, bands b and c) using a primer pair flanking region III
and I and found that band b contains breakpoints between
Chr21 38840448–38840454 and Chr21 41792689–41792695,
and band c contains breakpoints between Chr21 38840754–
38840760 and Chr21 41792689–41792695 (Figure 3F). Interest-
ingly, both ERG and TMPRSS2 utilize a common motif
(TGT/AGGGA/T) for break/ligation (Figure 3H).
For TMPRSS2:ETV1 translocation, two breakpoints between
Chr7 13991147–13991153 or Chr7 13991182–13991188 and
Chr21 41798889–41798895 were revealed by sequencing of
PCR product d (Figure 3G, middle panel), containing a common
CCAGG/CAA motif as their break/ligation sites (Figure 3I). An
additional breakpoint between ETV1 and TMPRSS2 at Chr7
13991254 and Chr21 41791805 were identified from PCR pro-
duct e (Figure 3G, lower panel). Together, these mapping results
identified unique heptad repeats serving as breakpoints for
nonrandom ligation sites of tumor translocation.
Sensitization of Intronic AR Binding Sites
to Genotoxic Stress
Since AR agonists induced both intra- and interchromosomal
movements that involved the AR target gene TMPRSS2, we
hypothesized that the ERG gene might also harbor some
previously unsuspected AR binding sites, even though ERG
expression is not induced by AR agonists (Tomlins et al.,
2005). Because the identified ‘‘break’’ sites in ERG and
TMPRSS2 are adjacent to potential androgen responseCelements (AREs) or ARE half sites (Figure 4A, upper panel), we
conducted conventional ChIP analysis for AR recruitment across
the intronic translocation regions within the ERG and TMPRSS2
genes. As controls, we observed the binding of AR to PSA
promoter and to the recently identified ARE located 13.5 kb
upstream of the TMPRSS2 gene (ARE V) (Wang et al., 2007),
but no significant binding to either an AR negative binding region
in the TMPRSS2 gene (ARE III) (Wang et al., 2007) or the GAPDH
exon8 region (Figure 4A). Interestingly, upon DHT treatment, we
found that AR was clearly recruited to the ERG ‘‘break’’ site
regions A (corresponding to region II in Figure 3A), C, and D
(corresponding to region III in Figure 3A), TMPRSS2 ‘‘break’’
site region F (corresponding to region I in Figure 3A), and ETV1
‘‘break’’ site region H (corresponding to region IV in Figure 3A)
with temporal kinetics similar to these observed at known
positive AR binding sites (PSA promoter and TMPRSS2 ARE V)
(Figures 4A and S15A). AR was also recruited to a potential
ARE (region G) 2.5 kb upstream of the TMPRSS2 ‘‘break’’ site
(Figure 4A). In contrast, the ERG region B and the TMPRSS2
region E, neither of which harbor any apparent ARE nor serve
as break sites, showed no significant AR recruitment (Figure 4A).
To understand the synergistic effect of liganded-AR and gen-
otoxic stress on chromosomal translocation, we first examined
the DNA damage response marked by gH2AX in DHT-, IR-, or
DHT+IR-treated LNCaP cells. No significant enrichment of
gH2AX were detected at all the regions we tested with DHT
alone, and a moderate recruitment was observed upon IR treat-
ment alone with characteristic spreading to regions adjacent to
DSBs. Surprisingly, there was a striking enrichment of gH2AX
to the translocation regions (ERG regions A, C, and D, the
TMPRSS2 region F, and the ETV1 region H) after combined
treatment with DHT+IR (Figures S11 and S15B). Since Ku80
protein binds to DNA DSBs, nicks, gaps, and hairpins in
a sequence-independent manner and serves as a key compo-
nent of the NHEJ repair machinery (Critchlow and Jackson,
1998), we next applied Ku80 as a mark to validate site-specific
DSBs at translocation regions. Consistently, we observed that
Ku80 bound to the TMPRSS2 and ERG intronic AR binding sites
exclusively under the condition of combined treatment with DHT
and IR, but not to control regions within the ERG gene (Figures
4B–4D). These results demonstrated a site-specific sensitization
of AR-bound intronic sites to genotoxic stress-induced DSBs.
Because binding of nuclear receptors during transcriptional
activation is characteristically accompanied by covalent histone
modifications that mark structural changes of chromatin
(Metivier et al., 2006), we next tested whether intronic AR binding
causes histone modifications that facilitate sensitization of these
regions to genotoxic stress. Enhanced H3K79 methylation,
a mark of altered chromatin structure (Huyen et al., 2004), has
been observed to correlate with V(D)J recombination in B cells
(Ng et al., 2003). Histone H4K16 acetylation is also considered
as a mark for chromatin relaxation (Shogren-Knaak et al.,
2006) and is involved in DNA repair. We observed that DHT+IR
provoked robust accumulation of dimethyl H3K79 and H4K16
acetylation markers in the ERG regions A, C, D and the
TMPRSS2 site F (Figures S12A and S12B). TMPRSS2 ARE III
and GAPDH exon 8 regions, at which no breaks occurred,
provided negative controls. These data provide evidence thatell 139, 1069–1083, December 11, 2009 ª2009 Elsevier Inc. 1073
Figure 3. Identification of Breakpoints for TMPRSS2:ERG and TMPRSS2:ETV1 Translocations
(A) The tracks display the human genome coordinates (hg18 assembly). Red band, predicted potential DSBs based on ChIP-seq with anti-BrdU antibodies (see
the Experimental Procedures); boxes, exons; lines, introns; regions I to IV, DNA break points within corresponding loci.
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the androgen receptor acts to cause regional histone modifica-
tions at the intronic translocation sites.
As a 30-50 DNA helicase in yeast is required for GCR by
enhancing binding of the replication protein A (RPA) (Banerjee
et al., 2008), we tested whether binding of AR might induce the
recruitment of RPA, which is known to bind to and stabilize
single-stranded nontemplate DNA (Bochkarev and Bochkareva,
2004), by performing RPA ChIP analysis. Upon DHT stimulation
for 1 hr, RPA was rapidly recruited to the AR binding sites, per-
sisting even after 16 hr of DHT stimulation (Figure 4E). Consistent
with a key role for RPA in yeast GCR, treatment of LNCaP cells
with RPA2 siRNA inhibited both intra- and interchromosomal
translocations induced by DHT+IR (Figure 4F).Genotoxic Stress-Induced Enzymatic Machinery
Contributes to Chromosomal Breaks
at Intronic AR Binding Sites
Although irradiation may cause random DSBs in the genome, we
next investigated the roles of irradiation in generating site-
specific DSBs at translocation regions. Recently, Gadd45, which
is a well-known irradiation-induced protein, was shown to play
an important role in mediating AID actions by forming a functional
complex with AID (Rai et al., 2008). Gadd45 is also known to
function as a transcriptional coactivator for a number of nuclear
receptors (Yi et al., 2000). Normally, AID is expressed at a very
low level in LNCaP cells; however, we observed that AR agonists
and genotoxic stress both induced AID expression by 3-fold
and >60-fold, respectively (Figures 5A and 5B). Correspondingly,
the AID protein was highly induced in IR-treated cells as early as
4 hr (Figure 5C).
We therefore tested the potential roles of DHT-dependent
recruitment of AID/Gadd45 to AR, observing that AR interacted
with both AID and Gadd45 upon DHT+IR treatment
(Figure 5D). This interaction was DHT-dependent, because IR
alone did not induce such interactions (Figure S13). These data
suggested that the DHT- and IR-induced AID might be recruited
to the intronic translocation sites via direct binding of the
Gadd45/AID complex to liganded AR. Indeed, ChIP analysis of
anti-Myc-tagged AID (Figure S14A) revealed that AID was re-
cruited to the intronic AR-binding sites on ERG, TMPRSS2 and
ETV1 translocation regions, as well as to known AR targets
such as PSA promoter and TMPRSS2 enhancer, but not to
non-AR binding sites (Figures 5E and S15C). To further confirm
a functional role for AID and Gadd45 in AR-dependent tumor
translocations, we treated LNCaP cells with either DHT or
bicalutamide (Casodex [CDX]) and observed only minimal
recruitment of AID or Gadd45 to intronic AR binding sites in
CDX-treated cells (Figures 5F and 5G).(B) The fold change of the tag density in the double-strand break regions I, II, III,
(C and D) Conventional ChIP analysis with anti-BrdU antibodies on ERG and TM
(E–G) Identification and characterization of induced TMPRSS2:ERG and TMPRS
cells either nontransfected (E) or cotransfected with MeCP2 siRNA and FLAG-D
primers flanking regions II and I (E), regions III and I (F), or regions IV and I (G). Botto
(orange) with genomic position of starting and ending nucleotides shown. Red b
(H and I) Graphic illustration of translocation patterns corresponding to induced TM
sites are shown as red ovals (TMPRSS2:ERG) and blue ovals (TMPRSS2:ETV1).
CBecause AID mediates CSR and somatic hypermutation
(SHM) by initiating deamination of bases of single-stranded
nontemplate DNA during transcription (Chaudhuri et al., 2003),
we investigated whether recruitment of AID is essential for the
generation of DSBs by monitoring the enrichment of Ku80 at
the translocation regions under the condition of AID knockdown
by siRNA (Figure S8B). Knockdown of AID resulted in a dramatic
decrease in the Ku80 enrichment as shown by ChIP analysis
(Figure 5H), indicating an inhibition of DSBs generation in these
translocation regions. To further validate this finding, we also
used the BrdU/TdT assay to confirm that DSBs generated at
these intronic sites are mediated by AID (Figure 5I). Consistent
with these observations, siRNA knockdown of AID blocked the
induction of both intra- and interchromosomal translocations
(Figures 5J). The actual frequency of chromosomal translocation
events was quantitated by PCR analysis in serial dilution
experiments, which showed that the rate of translocation
induced by DHT+IR within 24 hr fell from 12 3 105 in control
siRNA samples to 3 3 105 in AID siRNA knockdown samples
(Figure 5K).
One hallmark of AID enzymatic activity is the induction of SHM
(Honjo et al., 2002). PCR amplification and sequencing of the
break region (ERG region A) after DHT+IR treatment revealed
evidence of the C/U and G/A mutations characteristic of
SHM (Figure 6A). These mutations were inhibited by knockdown
of AID prior to the treatment, suggesting that AID is actively
involved in the observed DSB generation at translocations sites.
In adjacent control regions (ERG region B), only basal mutation
rate was observed (Figure 6A). To examine the possibility that
AID may also play an obligatory role in mediating AR-induced
chromosomal movements, we performed AID knockdown in
PrEC and LNCaP cells, finding that AID did not exert any effects
on DHT-dependent interchromosomal movement, as revealed
by FISH analysis (Figure S16).
We also observed that the uracil-DNA glycosylase (UNG),
which recognizes the UG mismatch generated upon deamina-
tion of cytidine by AID and generates abasic sites in the C1
regions during CSR (Rajewsky and von Boehmer, 2008),
localized to both ERG and TMPRSS2 intronic AR binding sites
in DHT+IR-treated LNCaP cells (Figure 6B). The recruitment of
UNG was dependent on AID, indicated by reduced UNG recruit-
ment after the knockdown of AID (Figure 6C).
To determine whether AID also plays a role in SLC45A3:ETV1
chromosomal translocation identified in prostate cancer
(Tomlins et al., 2007), we assessed these translocation events
in DHT+IR-treated LNCaP cells after AID knockdown by specific
siRNAs. With combined treatment of DHT and IR, we detected
significant induction of SLC45A3:ETV1 translocation in LNCaP
cells, but not in PrECs, even though the expression of SLC45A3and IV after DHT treatment.
PRSS2 intronic break regions identified by ChIP-seq.
S2:ETV1 translocation breakpoints. Top: genomic DNA extracted from LNCaP
OT1L expression vector (F and G) was subjected to PCR amplification using
m: automated DNA sequencing aligned to ERG or ETV1 (green) and TMPRSS2
ox: common sequence shared by TMPRSS2 and ERG or ETV1.
PRSS2:ERG (H) and TMPRSS2:ETV1 (I) translocations. Potential break/fusion
Dotted line, distinct fusion patterns.
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was similarly induced by DHT between these two cell lines
(Figures S20A–S20C). However, knockdown of AID abolished
the induced SLC45A3:ETV1 translocation (Figure S20D). Simi-
larly, in the KG-1 myeloid cell line, the BCR:ABL1 translocation
is induced by high-dose irradiation, and knockdown of AID
caused a decrease in irradiation-induced BCR:ABL1 transloca-
tion (Figures S8D, S17A, and S17B), consistent with the previous
report that AID is required for c-Myc:IgH translocation (Robbiani
et al., 2008). While these findings strongly implicate the actions of
AID to facilitate the DNA breaks at the intronic AR binding sites,
they also raised the question whether other key enzymatic
machinery was combinatorially required for induced chromo-
somal breaks.
Contribution of PIWI-Regulated LINE-1 Repeat/ORF2
Endonuclease to Tumor Translocations
Intriguingly, DHT+IR was much less effective in inducing
chromosomal translocations in PrECs than in LNCaP cells
(Figures 6D, 6E, and S20B), even though the expression of the
TMPRSS2 and SLC45A3 genes were induced similarly by DHT
in both cell types (Figures S18 and S20C). This observation is
consistent with the possibility that cancer cells express
additional factors that predispose to genome instability (Peng
and Karpen, 2008). We therefore surveyed the mRNA expression
levels of a series of ‘‘epigenetic’’ modulators that have been
implicated in genome instability (Goldberg et al., 2007). Whereas
the expression of most of these modulators did not change,
a few (e.g., MOF1) did exhibit 2- to 3-fold higher expression
level in PrECs compared to LNCaP cells (data not shown), and
MOF knockdown noticeably enhanced the efficiency of both
intra- and interchromosomal translocations (Figure S19).
Strikingly, the most dramatic discrepant target we tested
between LNCaP cells and PrECs was PIWIL1 (9- to 10-fold)
(Figure 6F). PIWIs have been reported to suppress retrotranspo-
sition, including LINE-1 element during spermatogenesis (Aravin
et al., 2007), but more recent studies have also implicated its role
in somatic organs (Malone et al., 2009). Treatment of PrECs with
PIWIL1 siRNA caused induction of LINE-1 ORF2 expression
(Figures 6G and S8C). This finding raised the possibility that
PIWIs might serve as an unexpected but key component of
machinery that silences the expression of the LINE-1 encoded
ORF2 in normal prostate epithelial cells. Indeed, knockdown of
PIWIL1 enhanced the enrichment of gH2AX at ERG and
TMPRSS2 intronic translocation regions in PrECs (Figure 6H).
Despite its already low levels in LNCaP cells, further knockdown
of PIWIL1 elevated the DHT+IR-induced intra- and interchromo-
somal translocations (Figure 6I), whereas overexpression of
PIWIs in LNCaP cells largely inhibited the induced chromosomal
translocations (Figure 6J). Serial dilution experiment confirmed
that the actual translocation frequency rose to 39 3 105 in
LNCaP cell after PIWIL1 knockdown (Figure 6K).Figure 4. AR-Dependent Local Chromatin Structural Alteration Sensiti
(A–E) Top: schematic diagram showing the relative positions of break/fusion sites
AREs; red boxes, break/fusion sites; black arrows, relative positions of PCR prime
(C), and DHT+IR (D) for time courses as indicated. ChIP analyses were performe
(F) Examination of TMPRSS2:ERGb and TMPRSS2:ETV1b fusion transcripts wit
*p < 0.05.
CA series of observations, including the close relationship
between LINE-1 element and genome instability (Prak and
Haoudi, 2006), the potent endonuclease activity of LINE-1-
encoded ORF2 (Goodier et al., 2004), and the activation of
LINE-1 retrotransposition by irradiation (Farkash et al., 2006),
led us to address the possibility that expression of the LINE-1-en-
coded ORF2 endonuclease might itself exert a direct role in tumor
translocation. Indeed, the relative level of LINE-1 ORF2 tran-
scripts exhibited a significant (6-fold) increase in LNCaP cells
compared to PrECs, andORF2 expression was robustly induced
by genotoxic stress (Figures 7A and 7B). These data suggested
that ORF2 might function as an additional irradiation/genotoxic
stress-induced enzymatic machinery to mediate the chromo-
somal breaks involved in tumor translocations.
Consistent with this possibility, exogenous overexpression of
LINE-1 ORF2 (Figure S14B) was sufficient to cause DHT-depen-
dent DNA breaks at the established translocation sites, as
revealed by specific recruitment of Ku80 to ERG and TMPRSS2
intronic translocation regions, but not at other AR binding
regions, such as thePSApromoter (Figure 7C). However, expres-
sion of an endonuclease-inactive mutant of ORF2 (Goodier et al.,
2004) diminished the enrichment of Ku80 (Figure 7C). Further-
more, overexpression of the LINE-1 ORF2 induced a marked
increase in both intra- and interchromosomal translocations,
whereas the endonuclease-inactive mutant partially blocked
DHT+IR-induced translocations (Figure 7D). Interestingly, over-
expression of the endonuclease-inactive mutant of ORF2
reduced the DSBs generation marked by Ku80 recruitment at
ERG and TMPRSS2 intronic translocation regions in DHT+IR-
treated LNCaP cells, but with minimal effects on the recruitment
of AID to the same regions (Figures 7E and 7F). These data
suggest that the LINE-1 ORF2 contributes to DSB generation,
in combination with the parallel actions of AID.
Indeed, ChIP analysis revealed that LINE-1 ORF2 was selec-
tively recruited in a DHT-dependent fashion to the translocation
regions, as well as to the enhancer region of TMPRSS2, but not
to the promoter ofPSA (Figure 7G). However, we could not detect
any direct physical interaction between AR and LINE-1 ORF2,
suggesting the possibility that the recruitment of LINE-1 ORF2
may result from other events, including the AR-induced alter-
ations in local chromatin architecture, and the exposed A/T-rich
single-stranded DNA that might then attract LINE-1 ORF2 to
these chromatin regions. Importantly, the recruitment of ORF2
to translocation regions was not affected by removal of AID
(Figure 7H), supporting the model that irradiation-induced LINE-1
ORF2 and AID act as independent mechanisms that combinato-
rially contribute to DSB generation and tumor translocation.
Thus, we conclude that activation of LINE-1 ORF2 expression
in tumor cells appears to provide an additional endonuclease
activity that makes an important quantitative contribution
to ligand/genotoxic stress-induced tumor translocations. Thezes to Site-Specific Genotoxic Stress-Induced DSBs
and potential AREs located on ERG and TMPRSS2 loci. Blue boxes, potential
rs. Bottom: LNCaP cells were treated with DHT (107 M) (A, B, and E), IR (50 Gy)
d with indicated antibodies on indicated regions (n = 2, ± SEM).
h RPA2 siRNAs (n = 3, ± SEM).
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Figure 5. Mechanisms that Initiate Extended DNA Breaks in AR-Dependent Tumor Translocations
(A–C) Induction of AID expression by AR agonist and genotoxic stress (n = 3, ± SEM).
(D) DHT-dependent interaction between AR and AID. Immunoprecipitates of anti-AR were subjected to immunoblotting analysis with the indicated antibodies.
Immunoblotting of E2F1 was included as negative control.
(E) Ligand-dependent Myc-AID recruitment to AR-binding sites (n = 2, ± SEM).
(F and G) The recruitment of AID and Gadd45 to AR binding sites is mediated by liganded receptor. LNCaP cells were treated with ethanol (EtOH), DHT (107
M), or bicalutamide (CDX, 10 mM) for 1 hr followed by ChIP analyses with anti-Myc (F) or anti-AR and anti-Gadd45 (G) antibodies on the indicated regions
(n = 2, ± SEM).
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functional role of LINE-1 ORF2 in chromosomal translocation
has been further extended based on our findings that over-
expression of LINE-1 ORF2 endonuclease-inactive mutant
abolished DHT+IR-induced SLC45A3:ETV1 translocation (Fig-
ure S20E). Therefore, it is highly possible that LINE-1 ORF2
has a general function in facilitating chromosomal breaks and
global genome instability in cancer cells.
DISCUSSION
A long-standing concept in tumor translocation has been that
genotoxic stress causes direct, random DSBs that lead to
random translocations, with selection of those conferring growth
advantage. Here, by devising and investigating a model of tumor
translocations that fully mimics the frequency of in vivo events
without proliferative selection, we suggested that, rather, there
is a site-selective immediate pattern of DSBs that ultimately
dictate the pattern of tumor translocations. This system has
permitted the identification of several unexpected mechanisms,
some sequential and others combinatorial, by which the
androgen receptor acts in concert with genotoxic stress as
parallel pathways to direct rapid, site-specific, and cell type-
specific tumor translocations in the absence of proliferative
selection (Figure 7I). Translocation breakpoint preferences are
dictated both by (1) site-specific binding of liganded-AR at
intronic translocation regions that trigger rapid intra- and inter-
chromosomal interactions, which results in spatial proximity
required for translocations, and (2) induced alterations of local
chromatin architecture are permissive for sensitizing these
regions to genotoxic stress. These transcription-related events,
in combination with activation and induction of specific enzy-
matic machineries by ligand and genotoxic stress, mechanisti-
cally underlie the extended DNA breaks at the critical intronic
AR binding sites. Thus, rather than being entirely the conse-
quence of random damage-induced DSBs, with selection for
the resulting tumor translocations that confer putative growth
advantages as is commonly hypothesized, there appears to
have an initial selective sensitization in a site-specific manner
that presages the observed tumor translocations in prostate
cancer. Therefore, our findings suggest the provocative concept
that liganded receptor acts, in a sense, as a mutagen, licensed
by the enzymatic machinery activated by genotoxic stress.
One initial puzzle was how the various TMPRSS2 fusion part-
ners were brought together for DNA recombination. We found
that AR bound to multiple intronic regions near break sites in
TMPRSS2, ERG, and ETV1 genes, juxtaposing DNA breaks for
subsequent recombination. This spatial proximity induced by
a specific transcription program is reminiscent of the DNA rear-
rangement in developing B cells, thus suggesting that a general
strategy is exploited for DNA rearrangement in tumorigenesis,
as well as during normal development. The requirements of a(H and I) AID contributes to DSB generation. ChIP analyses were performed on co
anti-Ku80 antibodies (n = 2, ± SEM) (H) or anti-BrdU antibody followed by BrdU
(J) Examination of TMPRSS2:ERGb and TMPRSS2:ETV1b fusion transcripts in L
(K) Left: representative agarose gels with PCR products corresponding to TMPRES
of control or AID siRNA transfected LNCaP cells were subjected to PCR with pri
*p < 0.05, **p < 0.01, ***p < 0.001.
Cnuclear motor for the induced proximity permitted our demon-
stration that the induction of this spatial proximity is actually
prerequisite for the induced translocation events.
Our data indicate that AR acts in concert with a number of key
enzymes induced by androgens and genotoxic stress, including
AID, previously considered to be a B cell-specific factor (Chaud-
huri etal., 2003),Gadd45,and,quite unexpectedly, the LINE-1-en-
coded ORF2, to license extended DSBs. AID is recruited to the in-
tronic AR binding sites as part of the genotoxic stress-induced
Gadd45/AID complex. These recruitments are postulated to be
permissive for potentiating the occurrence of specific transloca-
tion breakpoints that we have mapped within the TMPRSS2,
ERG, and ETV1 genes. Our data further suggest that only 20%
of intronic AR binding sites exhibit induced DSBs. We have further
documented that these breaks are marked by the recruitment
of Ku80 and by direct incorporation of BrdU at these sites. The
presence of microhomology in multiple TMPRSS2:ERG and
TMPRSS2:ETV1 fusion sites lends further support for the model
that there are staggered sites of DNA breakage as might be ex-
pected from the sequential actions of AID and UNG, analogous
to their predicted functions in CSR (Stavnezer et al., 2008).
Further, we observed the mutations characteristic of somatic
hypermutation within the short region of AID binding sites, reflect-
ing actions of AID at these intronic break sites. Consistent with
our findings, AID has been recently reported to be required for
c-myc:IgH translocations in B cells (Robbiani et al., 2008).
A key challenge was to identify specific machineries altered in
tumors that might sensitize the cell to tumor translocations. The
observation that the DHT+IR-induced chromosomal transloca-
tions observed in prostate cancer cells were not detected in
normal prostate epithelial cells led to the discovery of the critical,
independent role of the PIWI-regulated LINE-1 encoded-ORF2
endonuclease in translocation events. Thus, in addition to the
induction of AID in prostate cancer cells, we have uncovered
a second, unexpected component of this sensitization mecha-
nism based on the diminished expression of PIWIs, which serves
as a dedicated protective strategy to block retrotransposition of
LINE-1 elements to ensure genome stability in germ cells
(O’Donnell and Boeke, 2007). Surprisingly, we found that the
level of PIWIL1 was dramatically lower (>9-fold) in LNCaP cells
than in normal prostate epithelial cells. Even at this low level in
LNCaP cells, knockdown with specific siRNA caused a further
deprotection of the genome, resulting in increased chromosomal
translocations.
To our surprise, even in the absence of genotoxic stress, the
ORF2 endonuclease appears to be capable of targeting to the
intronic AR bound sites to license DNA breakage, which
emphasizes its independent, parallel function to AID in gener-
ating DSBs at the translocation sites. Our findings are consistent
with the reported elevation of the LINE-1 ORF2 endonuclease
activity in prostate cancer and the inducibility of this enzymentrol siRNA or AID siRNA-transfected, DHT+IR-treated (4 hr) LNCaP cells with
labeling by TdT (I) on indicated regions.
NCaP cells transfected with AID siRNA (n = 3, ± SEM).
S2:ERGa translocations (as illustrated in Figure 3H, band a). The genomic DNA
mers flanking ligation site (red oval). Right: statistical analysis (n = 3, ± SEM).
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Figure 6. Protective Effects of PIWIs on Chromosomal Translocation
(A) Left: summary of identified RGYW/WRCY motif related mutation. The fusion chromatins of ERG region A in control siRNA and AID siRNA samples or ERG
region B were amplified as in Figure 3E. Right: columns, mean of three experiments (94 bacterial colonies per sample per experiment); bars, ± SEM. *p < 0.05.
(B) Ligand-dependent UNG recruitment to intronic regions of TMPRSS2 and ERG loci (n = 2, ± SEM).
(C) Recruitment of UNG to translocation regions is AID dependent (n = 2, ± SEM).
(D) Quantitation of induced TMPRSS2:ERGb and TMPRSS2:ETV1b fusion transcripts in LNCaP or PrEC cells. NPT, normal prostate tissue. (n = 3, ± SEM.)
(E) Statistical comparison of induced TMPRSS2:ERGb (left) and TMPRSS2:ETV1b (right) fusion transcripts LNCaP and PrEC cells (48 samples per group;
n = 3, ± SEM).
(F) The relative expression level of PIWIL1 in LNCaP and PrEC cells (n = 3, ± SEM).
(G) The expression level of LINE-1 ORF2 was examined in PrEC cells transfected with indicated siRNAs (n = 3, ± SEM).
(H) PIWIL1 knockdown enhances gH2AX enrichment at intronic ERG and TMPRSS2 break/fusion sites (n = 2, ± SEM).
(I and J) Examination of TMPRSS2:ERGb and TMPRSS2:ETV1b fusion transcripts in LNCaP cells electroporated with PIWIL1 siRNA (I) or the indicated plasmids
(J) (n = 3, ± SEM).
(K) Left: representative agarose gels with PCR products corresponding to TMPRESS2:ERGa translocations (as illustrated in Figure 3H, band a). Right: statistical
analysis (n = 3, ± SEM).
*p < 0.05, **p < 0.01, ***p < 0.001.by irradiation (Farkash et al., 2006; Santourlidis et al., 1999), and
also with the documented role of PIWIs in silencing LINE-1
repeat movement during neurogenesis (Muotri et al., 2005).1080 Cell 139, 1069–1083, December 11, 2009 ª2009 Elsevier Inc.Because androgens exert important developmental roles in
the prostate, we suggest that similar events might occur in other
cancer types in which a selective, regulated DNA binding
Figure 7. PIWI Regulated LINE-1 ORF2 Endonuclease Contributes to Chromosomal Translocations
(A) The relative expression level of LINE-1 ORF2 in LNCaP and PrEC cells.
(B) IR-dependent induction of LINE-1 ORF2 expression (n = 3, ± SEM).
(C) Overexpression of LINE-1 ORF2 enhances Ku80 enrichment at intronic ERG and TMPRSS2 break/fusion sites (n = 2, ± SEM).
(D) Examination of TMPRSS2:ERGb and TMPRSS2:ETV1b fusion transcripts in LNCaP cells electroporated with indicated plasmids (n = 3, ± SEM).
(E and F) ORF2 contributes to DSBs generation independent of AID. ChIP analyses with anti-Ku80 (E) or anti-AID (F) antibodies were performed in LNCaP cells
electroporated with indicated plasmids (n = 2, ± SEM).
(G) Recruitment of LINE-1 ORF2 to translocation regions. ChIP analyses with anti-FLAG followed by anti-ORF2 antibodies were performed in LNCaP cells electro-
porated with FLAG-ORF2 plasmid (n = 2, ± SEM).
(H) The recruitment of ORF2 is independent of AID. ChIP analyses with anti-FLAG antibodies were performed in LNCaP cells electroporated with AID siRNA and
FLAG-ORF2 plasmid (n = 2, ± SEM).
(I) Schematic illustration of molecular mechanisms of nuclear receptor-dependent nonrandom chromosomal translocations.
*p < 0.05, **p < 0.01.
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transcription factor(s) serves to promote DNA rearrangement.
Finally, understanding the molecular mechanisms that underlie
tumor translocations and specific ‘‘epigenetic’’ strategies used
by normal cells to protect the genome against such deleterious
DNA rearrangements have the promise to provide insights into
the etiology of cancer and to facilitate the development of new
diagnostic/therapeutic approaches.
EXPERIMENTAL PROCEDURES
Cell Lines and Treatments
The prostate cancer cell line LNCaP was obtained from the American Type
Culture Collection. Human PrECs were obtained from Lonza and maintained
in PrEGM media. Transfection of LNCaP cells with siRNA and plasmid DNA
was performed with Lipofectamine2000 (Invitrogen) and Nucleofector Kit
R (Lonza), respectively. Transfection of PrECs with siRNA was performed
with DeliverX Plus siRNA transfection reagent (Panomics). MVA/T7RP-medi-
ated expression of LINE-1 proteins was performed as previous described
(Goodier et al., 2004). For induction of chromosomal translocation, LNCaP
cells or PrECs were grown in charcoal-stripped serum containing media for
48 hr followed by mock, DHT (107 M), g-irradiation (50 Gy) treatment, or
both. After treatment, the cells were reincubated for 24 hr before being har-
vested for appropriate assays. Cell viability in cultures before and after irradi-
ation was assessed by trypan blue exclusion.
Fluorescence In Situ Hybridization
PrECs or LNCaP cells were stimulated with vehicle or 107 M DHT for 1 hr. Cell
nuclei isolation and DNA-FISH was carried out according to a method
previously described (Hu et al., 2008), and the probes were synthesized by
Integrated DNA Technologies and listed in Table S1.
DNA-Break Labeling and Chromatin Immunoprecipitation
The labeling of transient DNA break(s) by BrdU was performed as described
(Ju et al., 2006). ChIP and two-step ChIP were performed as described
previously (Shang et al., 2000). The enrichment of the DNA template was
analyzed by quantitative PCR with the primers listed in Table S1.
Single-Cell Nuclear Microinjection Assays
The single-cell nuclear microinjection assays were performed as described
(Perissi et al., 2004).
Data Analysis and Statistics
Relative quantities of TMPRSS2:ERG and TMPRSS2:ETV1 fusion transcript
were normalized to Actin and further to the expression level of TMPRSS2.
The relative amount of each fusion transcript was then calibrated to DHT- or
DHT+IR-treated control samples as appropriate. Calibrated quantities are
indicated, and samples without detectable fusion transcript after 40 cycles
of amplification are indicated by 0 (Tomlins et al., 2007). Results are reported
as mean ± SEM of three independent experiments. Comparisons were
performed with a two-tailed paired Student’s t test (*p < 0.05, **p < 0.01,
***p < 0.001).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, 20
figures, and one table and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(09)01488-3.
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Note Added in Proof
While this manuscript was in press, we noted a recent publication suggesting
that AR induces physical interaction between the known translocation loci:
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